HopStem FDA Clearance for Stroke & Brain Injury Cell Therapy

Researcher examining neural stem cell cultures under a microscope, representing HopStem FDA clearance for stroke and brain injury stem cell therapy

Are you or a loved one living with the long-term effects of a stroke or brain injury? The struggle to regain movement and independence is a daily battle for millions. We understand the frustration of hitting a plateau in recovery when standard treatments stop working. A major breakthrough has just arrived that offers real hope […]

Stem Cell Therapy for Epilepsy: A 2026 Breakthrough in Seizure Control

Stem cell therapy for epilepsy - glowing brain with neural activity and stem cells

Living with drug-resistant epilepsy means facing the constant, unpredictable threat of seizures. When medications fail, the remaining options often involve invasive brain surgery that can permanently affect memory and cognition. You might feel like you are out of options. But what if there was a way to restore balance to the brain without removing tissue? […]

Revolutionary Stem Cell Therapy Offers New Hope for Brain Injury Recovery

Revolutionary Stem Cell Therapy Offers New Hope for Brain Injury Recovery

Are you struggling with the long-term effects of a concussion or traumatic brain injury? Do you worry that traditional treatments only mask symptoms without actually healing your brain? A groundbreaking discussion on the Broken Brains podcast reveals how stem cell therapy could transform brain injury treatment and offer real healing instead of temporary fixes. What Makes Stem […]

NYSCF and Janssen Partner on Neurodegenerative Disease Drug Discovery

NYSCF and Janssen Partner on Neurodegenerative Disease Drug Discovery

The New York Stem Cell Foundation Research Institute (NYSCF) and Janssen Research & Development, a Johnson & Johnson company, have partnered to accelerate the development of precision medicines for neurodegenerative diseases.  NYSCF’s AI-powered platform, using automated stem cell systems, will be leveraged to identify new drug targets and therapies. This collaboration combines NYSCF’s expertise in stem cell […]

Revolutionizing Neurodegenerative Disease Treatment with Pluripotent Stem Cells: Insights from Sana Biotechnology

Sana Biotechnology logo

In an exciting development for the field of stem cell research, Sana Biotechnology has unveiled promising preclinical data in the prestigious journal, Nature Biotechnology. This data underscores the potential of pluripotent stem cell-derived human glial progenitor cells (hGPCs) in treating neurodegenerative diseases. Sana Biotechnology’s innovative approach focuses on harnessing the power of pluripotent stem cells, […]